KLK15

KLK15
Identifiers
AliasesKLK15, ACO, HSRNASPH, kallikrein related peptidase 15
External IDsMGI: 2447533 HomoloGene: 77571 GeneCards: KLK15
Gene location (Human)
Chr.Chromosome 19 (human)[1]
Band19q13.33Start50,825,289 bp[1]
End50,837,213 bp[1]
RNA expression pattern
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez

55554

317652

Ensembl

ENSG00000174562

ENSMUSG00000055193

UniProt

Q9H2R5

n/a

RefSeq (mRNA)

NM_174865

RefSeq (protein)

NP_001264010
NP_001264011
NP_059979

n/a

Location (UCSC)Chr 19: 50.83 – 50.84 MbChr 7: 43.93 – 43.94 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Kallikrein-15 is a protein that in humans is encoded by the KLK15 gene.[5][6][7][8][9]

Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. In prostate cancer, this gene has increased expression, which indicates its possible use as a diagnostic or prognostic marker for prostate cancer. The gene contains multiple polyadenylation sites and alternative splicing results in multiple transcript variants encoding distinct isoforms.[9]

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000174562 - Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000055193 - Ensembl, May 2017
  3. ↑ "Human PubMed Reference:".
  4. ↑ "Mouse PubMed Reference:".
  5. ↑ Yousef GM, Scorilas A, Jung K, Ashworth LK, Diamandis EP (Feb 2001). "Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer". J Biol Chem. 276 (1): 53–61. doi:10.1074/jbc.M005432200. PMID 11010966.
  6. ↑ Yousef GM, Scorilas A, Magklara A, Memari N, Ponzone R, Sismondi P, Biglia N, Abd Ellatif M, Diamandis EP (Nov 2002). "The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer". Br J Cancer. 87 (11): 1294–300. doi:10.1038/sj.bjc.6600590. PMC 2408911. PMID 12439720.
  7. ↑ Lundwall A, Band V, Blaber M, Clements JA, Courty Y, Diamandis EP, Fritz H, Lilja H, Malm J, Maltais LJ, Olsson AY, Petraki C, Scorilas A, Sotiropoulou G, Stenman UH, Stephan C, Talieri M, Yousef GM (Jun 2006). "A comprehensive nomenclature for serine proteases with homology to tissue kallikreins". Biol Chem. 387 (6): 637–41. doi:10.1515/BC.2006.082. PMID 16800724.
  8. ↑ Diamandis, Eleftherios P.; Deperthes, David; Lundwall, Åke (Jun 2006). "Proceedings of the 1st International Symposium on Kallikreins, Lausanne, Switzerland, September 1-3 , 2005". Biol Chem. 387 (6): 635–824. doi:10.1515/BC.2006.081. PMID 16800723.
  9. 1 2 "Entrez Gene: KLK15 kallikrein-related peptidase 15".

Further reading

  • Diamandis EP, Yousef GM, Luo LY, et al. (2001). "The new human kallikrein gene family: implications in carcinogenesis". Trends Endocrinol. Metab. 11 (2): 54–60. doi:10.1016/S1043-2760(99)00225-8. PMID 10675891.
  • Diamandis EP, Yousef GM (2002). "Human tissue kallikrein gene family: a rich source of novel disease biomarkers". Expert Rev. Mol. Diagn. 1 (2): 182–90. doi:10.1586/14737159.1.2.182. PMID 11901813.
  • Dihanich M, Spiess M (1994). "A novel serine proteinase-like sequence from human brain". Biochim. Biophys. Acta. 1218 (2): 225–8. doi:10.1016/0167-4781(94)90018-3. PMID 8018728.
  • Yousef GM, Chang A, Scorilas A, Diamandis EP (2000). "Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4". Biochem. Biophys. Res. Commun. 276 (1): 125–33. doi:10.1006/bbrc.2000.3448. PMID 11006094.
  • Gan L, Lee I, Smith R, et al. (2001). "Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region". Gene. 257 (1): 119–30. doi:10.1016/S0378-1119(00)00382-6. PMID 11054574.
  • Takayama TK, Carter CA, Deng T (2001). "Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR". Biochemistry. 40 (6): 1679–87. doi:10.1021/bi002129r. PMID 11327827.
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
  • Yousef GM, Scorilas A, Katsaros D, et al. (2003). "Prognostic value of the human kallikrein gene 15 expression in ovarian cancer". J. Clin. Oncol. 21 (16): 3119–26. doi:10.1200/JCO.2003.09.111. PMID 12915603.
  • Hillman RT, Green RE, Brenner SE (2005). "An unappreciated role for RNA surveillance". Genome Biol. 5 (2): R8. doi:10.1186/gb-2004-5-2-r8. PMC 395752. PMID 14759258.
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
  • The MEROPS online database for peptidases and their inhibitors: S01.081


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.